QuantHealth simulates clinical trials before they run, modelling how a patient population would respond to a therapy so sponsors can test protocol decisions in silico. Trial design choices — inclusion criteria, dosing, endpoints, comparator arms — are otherwise locked in with limited evidence and cost hundreds of millions when wrong.
The platform is built on multi-source clinical and molecular data, and the commercial claim is de-risking rather than replacement: simulation informs the protocol, the trial still runs. That framing is the correct one, both scientifically and for regulators.
Simulation credibility rests on validation against completed trials, so sponsors should ask for retrospective accuracy on studies with known outcomes in comparable indications. Engagement is enterprise with pricing quoted per programme.
